HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Holt, R. I.G. Search for Related Content PubMed PubMed Citation Articles by Holt, R. I.G. Social Bookmarking                What's this?

Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes

Response to consensus statement

Endocrinology and Metabolism Unit, Development Origins of Health and Disease Division, School of Medicine, University of Southampton, Southampton, U.K

Address correspondence to Dr. R.I.G. Holt, Level F, Centre Block, MP 113, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, U.K. E-mail: righ@soton.ac.uk

The first 20% of the full text of this article appears below.

I commend the authors of the consensus statement in Diabetes Care for focusing our attention on the physical health of people with schizophrenia and serious mental illnesses and on the need for glucose monitoring (1). There is little consensus about the risk of diabetes in people with schizophrenia and the role of atypical antipsychotic drugs (2–4). Recently I was a member of a group of international psychiatrists and diabetologists who reviewed the evidence surrounding this issue (proceedings have been published in a supplement to the April 2004 issue of the British Journal of Psychiatry). I was, therefore, interested to see that the conclusions published in Diabetes Care differed . . . [Full Text of this Article]

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. I. G. Holt, C. Bushe, and L. Citrome Diabetes and schizophrenia 2005: are we any closer to understanding the link? J Psychopharmacol, November 1, 2005; 19(6_suppl): 56 - 65. [Abstract] [PDF]

				E. J. Barrett Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Response to Holt, Citrome and Volevka, Isaac and Isaac, and Boehm et al. Diabetes Care, August 1, 2004; 27(8): 2089 - 2090. [Full Text] [PDF]